UNASSIGNED: The aim of the present report was to investigate the efficacy of local @entity479 injection and oral administration contralateral to a severe contracted scar of large endoscopic submucosal dissection (ESD) for gastric cancer. Among 254 cases that underwent gastric ESD, seven @entity1 underwent resection of more than three-quarters of the circumference of the stomach. Two @entity1 were excluded because they did not meet curative resection criteria of Japan Gastroenterological Endoscopy Society. Therefore, in five @entity1 , circumferentiality, symptom appearance period, and weight loss period were examined. Effect of a contralateral normal mucosa incision for releasing the stenosis followed by local injection and oral @entity230 were also examined. Abdominal bloating, vomiting, and loss of appetite appeared 42 days on average after gastric ESD, whereas weight loss >5   kg was observed an average of 52.6 days after gastric ESD. Average contralateral mucosal incision length was 51   mm, whereas the average mucosal incision width was 31   mm. All @entity1 underwent a mucosal incision and were given a local injection of 100   mg @entity2995 . Two @entity1 received an additional 20   mg oral @entity479 . In cases combined with oral @entity479 , there was no re-stenosis after the mucosal incision, but two to three balloon dilatations were necessary in three cases in which oral @entity230 were not given. This method is considered useful for stenosis after large ESD for gastric cancer.

Novel method for the management of stenosis after gastric endoscopic submucosal dissection: Mucosal incision with XXXX injection contralateral to the severely contracted scar.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2995 :: ('MESH:D014222', 'Chemical') :: ['triamcinolone acetonide'] @entity230 :: ('MESH:D013256', 'Chemical') :: ['steroids'] @entity479 :: ('D013256', 'Chemical') :: ['steroid']
@entity479 :: (D013256,Chemical) :: ['steroid']
